# US Breast Imaging Market

> US Breast Imaging Market Research Report: Size, Share, Trend Analysis By Technology (Mammography, Ultrasound, Magnetic Resonance Imaging, Tomosynthesis, Breast Biopsy), By Product (Systems, Consumables, Software), By Applications (Screening, Diagnosis, Treatment Planning) and By End Use (Hospitals, Diagnostic Centers, Research Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.32%
- **2024:** $ 1,214.39 Million
- **2025:** $ 1,315.43 Million
- **2035:** $ 2,925.27 Million
- **Key Players:** Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), Philips (NL), Fujifilm (JP), Canon Medical Systems (JP), Carestream Health (US), Konica Minolta (JP), Agfa HealthCare (BE)

**Report ID:** MRFR/MED/51272-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-breast-imaging-market-53033

---

## Market Summary

## **US Breast Imaging Market Overview**

As per MRFR analysis, the US Breast Imaging Market Size was estimated at 678.3 (USD Million) in 2023.The US Breast Imaging Market Industry is expected to grow from 750 (USD Million) in 2024 to 1,350 (USD Million) by 2035. The US Breast Imaging Market CAGR (growth rate) is expected to be around 5.489% during the forecast period (2025 - 2035).

## **Key US Breast Imaging Market Trends Highlighted**

The US Breast Imaging Market is currently experiencing significant growth due to a convergence of market drivers, including the increasing incidence of breast cancer and heightened awareness surrounding early detection. Government initiatives focused on improving breast cancer screening guidelines and expanding access to imaging technologies are reinforcing this trend. For instance, the American College of Radiology advocates for regular mammography screenings, thereby encouraging early intervention strategies. Additionally, advances in imaging modalities, such as 3D mammography and MRI, are enhancing diagnostic accuracy, driving adoption among healthcare providers and patients alike.

The field of breast imaging has many opportunities, especially due to the growing use of telemedicine and remote monitoring technologies. Because of geographical limitations and the increasing focus on equitable healthcare, remote imaging interpretations can greatly help neglected rural areas. In addition, the constant efforts of researchers will soon lead to the development of new imaging technologies, which will improve diagnosis and treatment outcomes for breast cancer. Recent changes also show an increase in the demand for outpatient services and mobile imaging units, which greatly aids women who face challenges in traveling to conventional healthcare centers.

There is also a notice of increased integration of artificial intelligence in imaging processes, enhancing operational efficiencies and detection rates. These trends highlight a progressive shift towards patient-centered care in the US breast imaging sector, ensuring better service delivery and lower costs. The continual synergy between technological advancements and regulatory support will define the future landscape of breast imaging in the US.

Source: Primary Research, Secondary Research, _Market Research Future_ Database, and Analyst Review

## **US Breast Imaging Market Drivers**

### **Increasing Incidence of Breast Cancer**

The US Breast Imaging Market Industry is experiencing significant growth due to the increasing incidence of breast cancer. According to the American Cancer Society, in 2023 alone, approximately 297,790 new cases of invasive breast cancer are projected to be diagnosed in women in the United States. This alarming statistic represents a continued rise, emphasizing the critical need for advanced imaging technologies in early detection and diagnosis. As public awareness and screening initiatives grow, hospitals and clinics are investing in state-of-the-art imaging equipment such as digital mammography and breast tomosynthesis, which are essential for improving patient outcomes.

Organizations like the National Cancer Institute have also launched programs aimed at enhancing screening accessibility, further fueling the demand for breast imaging services across the nation. Consequently, with the growing number of breast cancer cases, the US Breast Imaging Market is expected to expand significantly.

### **Technological Advancements in Imaging Techniques**

The US Breast Imaging Market Industry is witnessing substantial growth, primarily due to rapid advancements in imaging technologies. Innovations such as 3D mammography (breast tomosynthesis) and magnetic resonance imaging (MRI) are revolutionizing the way breast cancer is detected and diagnosed. According to data from the Food and Drug Administration, the adoption of 3D mammography has led to a 15% increase in breast cancer detection rates compared to traditional 2D mammography. These advancements not only enhance diagnostic accuracy but also improve patient comfort and experience.

Institutions like the Radiological Society of North America promote these technologies through various programs, showcasing their benefits and driving adoption among healthcare providers across the United States. As these technologies continue to evolve, the US Breast Imaging Market will likely see robust growth.

### **Government Initiatives and Funding**

The growth of the US Breast Imaging Market Industry is significantly driven by robust government initiatives and funding aimed at enhancing breast cancer screening and treatment. The Affordable Care Act has mandated coverage for preventive services, including mammograms, which has increased the number of women receiving essential screenings. In addition, the National Breast and Cervical Cancer Early Detection Program receives federal funding from the Centers for Disease Control and Prevention, targeting low-income women and providing access to vital screening services.

This substantial backing from government entities not only boosts awareness but also underscores the importance of early detection, subsequently increasing the demand for advanced breast imaging technologies. As public policies continue to support breast health initiatives, the US Breast Imaging Market is poised for substantial growth.

## **US Breast Imaging Market Segment Insights**

### **Breast Imaging Market Technology Insights**

The Technology segment of the US Breast Imaging Market plays a crucial role in the early detection and diagnosis of breast cancer, significantly impacting treatment outcomes and survival rates. Within this segment, various imaging modalities including Mammography, Ultrasound, Magnetic Resonance Imaging (MRI), Tomosynthesis, and Breast Biopsy utilize advanced techniques to provide detailed images of breast tissue. Mammography is the most established form of screening in the United States, known for its effectiveness in identifying abnormalities, and has contributed to the decrease in breast cancer mortality.

Ultrasound complements Mammography, often used for further evaluation of suspicious findings, particularly in dense breast tissue where mammograms may have limitations. Magnetic Resonance Imaging has gained importance due to its high sensitivity in detecting breast lesions and providing comprehensive imaging, especially for high-risk patients. Tomosynthesis, also known as 3D Mammography, is a newer technology that allows radiologists to analyze breast tissue layer by layer, reducing the chances of false positives and improving diagnostic accuracy. Additionally, Breast Biopsy procedures remain critical in confirming diagnoses and are increasingly being performed with imaging guidance to ensure precise sampling.

The advancements in these technologies result from a growing emphasis on personalized medicine and preventive care strategies in the US, supported by various health organizations that promote early screening and regular check-ups. These developments highlight the dynamic nature of the US Breast Imaging Market in the Technology segment, showcasing its pivotal role in improving healthcare outcomes and the ongoing need for innovation in breast cancer care.

Source: Primary Research, Secondary Research, _Market Research Future_ Database, and Analyst Review

### **Breast Imaging Market Product Insights**

The US Breast Imaging Market, focusing on the Product segment, reflects a vital part of healthcare technology dedicated to early detection and diagnosis of breast cancer. Within this market, the critical areas include Systems, Consumables, and Software. Systems are pivotal, as they form the backbone of imaging capabilities, with technologies like digital mammography and ultrasound playing significant roles in providing clear visualizations for assessments. Consumables, encompassing items like imaging agents and biopsy needles, are essential for the functionality and effectiveness of imaging procedures, ensuring quality and safety during examinations.

Meanwhile, Software is increasingly important for the analysis and management of imaging data, enhancing diagnostic accuracy and workflow efficiency. The growing adoption of advanced software technologies aids in improved patient outcomes by leveraging data analytics and artificial intelligence. This market is also shaped by rising awareness of breast cancer, leading to increased screening rates across the United States. Consequently, the US Breast Imaging Market is poised for steady growth, driven by innovations, demographic changes, particularly among aging populations, and the need for accessible healthcare solutions.

Overall, the integration of these elements underscores the importance and dynamics within this crucial healthcare market.

### **Breast Imaging Market Application Insights**

The Application segment of the US Breast Imaging Market encompasses critical areas such as Screening, Diagnosis, and Treatment Planning, which are pivotal in enhancing patient outcomes and improving early detection of breast cancer. Screening applications are particularly important as they help in the timely identification of anomalies, thereby significantly contributing to reducing mortality rates associated with breast cancer; this has led to widespread implementation of screening programs across the United States. Diagnosis is equally vital as it relies heavily on advanced imaging technologies to accurately assess suspicious findings, providing essential information for effective treatment strategies.

Treatment Planning utilizes imaging results to design personalized care approaches, ensuring optimal therapeutic interventions for patients. The market trends indicate a growing emphasis on innovative imaging techniques and AI integration, which promise to enhance diagnostic accuracy and streamline workflows. This segment faces challenges such as rising healthcare costs and the need for continuous education among healthcare professionals. However, the increasing prevalence of breast cancer, coupled with heightened awareness and technological advancements, presents substantial opportunities for growth and development in this segment of the US Breast Imaging Market.

### **Breast Imaging Market End Use Insights**

The End Use segment of the US Breast Imaging Market plays a crucial role in shaping industry dynamics, driven primarily by the demand for accurate and early detection of breast cancer. Hospitals are significant players in this space, often equipped with the latest technology and staffed by specialized professionals, thus ensuring high-quality patient care. Diagnostic Centers contribute by providing focused imaging services that cater to outpatient needs, often streamlining procedures to enhance patient experience. Research Institutes are vital for innovation, conducting studies that lead to advancements in imaging techniques and technologies.

Moreover, these institutions collaborate with medical facilities to implement findings that improve diagnostic accuracy, ultimately influencing treatment pathways. Factors such as increasing awareness of breast cancer screening, advancements in imaging technologies, and supportive government policies regarding early detection are key growth drivers across these settings. However, challenges such as high operational costs and the need for continuous training and equipment upgrades tend to persist in these environments, shaping the overall landscape of the US Breast Imaging Market.

The interplay of these sectors highlights not only their individual contributions but also their collective impact on enhancing healthcare outcomes for patients in the United States.

## **US Breast Imaging Market Key Players and Competitive Insights**

The US Breast Imaging Market is characterized by a diverse range of players, each striving to establish a foothold by offering innovative solutions to enhance diagnostic accuracy and patient outcomes. This market encompasses a variety of imaging modalities, including mammography, ultrasound, and MRI, which are crucial in the early detection and monitoring of breast cancer. Competitive insights are shaped by technological advancements, regulatory changes, and shifting market demands, which encourage companies to adapt swiftly and effectively.

As the population ages and awareness of breast health continues to rise, the competition in this market intensifies, pushing companies to differentiate their products through improved performance, enhanced functionalities, and superior customer service. Siemens Healthineers plays a significant role in the US Breast Imaging Market, leveraging its advanced imaging technologies and strong market presence. Known for its high-quality imaging systems, Siemens Healthineers maintains a robust portfolio that includes state-of-the-art mammography systems equipped with digital and tomosynthesis capabilities, as well as ultrasound systems designed specifically for breast imaging applications.

The company’s commitment to research and development enables it to introduce cutting-edge solutions that enhance the precision and efficiency of breast cancer detection. Furthermore, Siemens Healthineers has established a strong network of partnerships and collaborations that bolster its market position, allowing it to effectively address the evolving needs of healthcare providers and patients throughout the United States. United Imaging Healthcare has emerged as a key player in the US Breast Imaging Market, offering a wide range of advanced imaging solutions tailored for breast health.

The company is recognized for its commitment to innovation and has developed a comprehensive line of mammography systems that emphasize high-resolution imaging and cost-effectiveness. United Imaging Healthcare benefits from strategic mergers and acquisitions that have expanded its capabilities and market reach within the US, reinforcing its competitive position. Its portfolio includes not only mammography systems but also integrated solutions that encompass advanced imaging technologies, thereby enabling healthcare providers to deliver more effective patient care. With a focus on quality and technological advancement, United Imaging Healthcare is well-positioned to meet the growing demand for breast imaging services in the United States.

### **Key Companies in the US Breast Imaging Market Include:**

- [Siemens Healthineers](https://www.siemens-healthineers.com/en-us/clinical-specialities/oncology/breast-care-solutions)
- United Imaging Healthcare
- AgfaGevaert
- Canon Medical Systems
- Neusoft Medical Systems
- McKesson
- Curae Health
- Konica Minolta
- Philips
- Fujifilm
- Carestream Health
- Radiology Partners
- Hologic
- GE Healthcare
- RadNet

## **US Breast Imaging Market Industry Developments**

In recent months, the US Breast Imaging Market has experienced notable developments, including a focus on advancements in technology and increasing demand for mammography services. Siemens Healthineers announced innovative upgrades to their mammography equipment, enhancing image quality and efficiency. Canon Medical Systems also reported advancements in breast imaging technology, which are expected to improve diagnostic accuracy. In June 2023, Hologic expanded its partnership with Radiology Partners to enhance access to its breast imaging solutions, addressing the increasing need for early detection.

On the mergers and acquisitions front, a significant acquisition occurred in August 2023 when GE Healthcare acquired a minority stake in a breast imaging technology startup, thereby strengthening its portfolio in innovative imaging solutions. The market growth is influenced by the rising prevalence of breast cancer and regulatory initiatives aimed at improving screening programs across the United States. 

Furthermore, the valuation of companies like Philips and Fujifilm has seen positive growth, reflecting strong investor confidence. Over the past few years, from 2021 to 2023, several companies have invested heavily in Research and Development to advance breast imaging technologies, directly impacting patient care and health outcomes.

## **US Breast Imaging Market Segmentation Insights**

### **Breast Imaging Market Technology Outlook**

- Mammography
- Ultrasound
- Magnetic Resonance Imaging
- Tomosynthesis
- Breast Biopsy

## **Breast Imaging Market Product Outlook**

- Systems
- Consumables
- Software

### **Breast Imaging Market Application Outlook**

- Screening
- Diagnosis
- Treatment Planning

### **Breast Imaging Market End Use Outlook**

- Hospitals
- Diagnostic Centers
- Research Institutes

## Market Drivers

### Growing Awareness and Education

Public awareness campaigns and educational initiatives regarding breast health are significantly influencing the breast imaging market. Organizations such as the Susan G. Komen Foundation and the American Cancer Society are actively promoting the importance of regular screenings and early detection. This heightened awareness is leading to increased participation in screening programs, which is crucial for early diagnosis and treatment. As more women become informed about the risks associated with breast cancer, the demand for imaging services is expected to rise. The breast imaging market is likely to benefit from this trend, as healthcare providers respond to the growing need for accessible and effective imaging solutions. This shift may also encourage innovations in imaging technologies to meet the evolving needs of patients.

### Rising Incidence of Breast Cancer

The increasing incidence of breast cancer in the US is a primary driver for the breast imaging market. According to the American Cancer Society, approximately 1 in 8 women will develop invasive breast cancer in their lifetime. This alarming statistic underscores the necessity for effective screening and diagnostic tools. As awareness of breast cancer rises, more women are seeking regular screenings, which in turn propels demand for advanced imaging technologies. The breast imaging market is expected to grow significantly, with projections indicating a compound annual growth rate (CAGR) of around 8.32% over the next several years. This growth is largely attributed to the need for early detection and improved treatment outcomes, making it imperative for healthcare providers to invest in state-of-the-art imaging solutions.

### Increase in Healthcare Expenditure

The rising healthcare expenditure in the US is a significant factor driving the [breast imaging market](../../../reports/breast-imaging-market-5612). As healthcare budgets expand, there is a greater allocation of funds towards preventive care and diagnostic services, including breast imaging. The Centers for Medicare & Medicaid Services (CMS) reported an increase in spending on outpatient services, which encompasses breast imaging technologies. This trend suggests that healthcare providers are prioritizing investments in advanced imaging equipment to enhance patient care. The breast imaging market is expected to benefit from this increase in funding, as facilities seek to upgrade their imaging capabilities. Furthermore, the emphasis on value-based care may lead to more comprehensive screening programs, ultimately improving patient outcomes and driving market growth.

### Advancements in Imaging Technologies

Technological innovations in imaging modalities are transforming the breast imaging market. The introduction of 3D mammography, also known as tomosynthesis, has enhanced the accuracy of breast cancer detection, reducing false positives and unnecessary biopsies. Furthermore, the integration of digital imaging systems allows for better image quality and faster processing times. As healthcare facilities adopt these advanced technologies, the market is likely to experience substantial growth. The US breast imaging market is projected to reach approximately $4 billion by 2027, driven by the increasing adoption of these cutting-edge imaging solutions. Additionally, the development of portable imaging devices may further expand access to breast imaging services, particularly in underserved areas.

### Regulatory Support for Screening Programs

Regulatory frameworks in the US are increasingly supporting breast cancer screening initiatives, which is a key driver for the breast imaging market. The Affordable Care Act mandates that health insurance plans cover mammograms without cost-sharing for women aged 40 and older. This policy has led to a surge in screening rates, as financial barriers are reduced. Additionally, the US Preventive Services Task Force recommends biennial screening mammography for women aged 50 to 74, further solidifying the importance of regular imaging. As these regulations continue to evolve, the breast imaging market is likely to see sustained growth, with more women accessing necessary imaging services. The financial backing from insurance providers also encourages healthcare facilities to invest in advanced imaging technologies.

## Future Outlook

The [Breast imaging Market](https://www.marketresearchfuture.com/reports/breast-imaging-market-5612) is projected to grow at an 8.32% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising incidence of breast cancer.

**New opportunities:**

- Development of AI-driven diagnostic tools for enhanced accuracy Expansion of mobile breast imaging units for rural access Integration of telehealth services for remote consultations

By 2035, the breast imaging market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Technology: Mammography (Largest) vs. Tomosynthesis (Fastest-Growing)

In the US breast imaging market, mammography holds the largest market share, significantly contributing to the overall prevalence of breast cancer screening. This segment is well-established, with widespread acceptance based on its effectiveness in early detection. On the other hand, tomosynthesis is gaining traction, emerging as an innovative approach that provides clearer, 3D images, thus facilitating better tumor detection and reducing false positives.

Growth trends in the US breast imaging market are being driven by advancements in technology and increased awareness of breast health. More healthcare providers are adopting advanced imaging modalities such as tomosynthesis and MRI due to their enhanced diagnostic capabilities. Additionally, there is a rising demand for minimally invasive procedures, contributing to the increased utilization of ultrasound and breast biopsy modalities. The combination of these factors is reshaping screening protocols and improving patient outcomes.

Mammography: Dominant vs. Tomosynthesis: Emerging

Mammography remains the dominant technology in the breast imaging market due to its established role in regular screening and effective cancer detection. Its familiarity among healthcare providers and patients solidifies its position as the go-to imaging modality. Conversely, tomosynthesis represents an emerging technology that offers 3D imaging capabilities, addressing some limitations of conventional mammography. As the demand for breast cancer screening evolves, tomosynthesis is capturing the interest of both radiologists and patients, particularly for its ability to improve the accuracy of assessments and minimize unnecessary callbacks. This juxtaposition highlights the ongoing transformation within the breast imaging segment, balancing tried-and-true methods with cutting-edge innovations.

### By Product: Systems (Largest) vs. Consumables (Fastest-Growing)

In the US breast imaging market, the product segment is dominated by systems, which hold the largest market share. These advanced imaging systems include digital mammography, ultrasound, and MRI technologies, playing a crucial role in early detection and diagnosis. Consumables follow closely, with a significant share due to the ongoing need for supportive products like contrast agents, biopsy needles, and other disposable items necessary for imaging procedures. 

The growth trends within this segment reveal that consumables are experiencing the fastest growth rate, driven by increasing procedural volumes and advancements in imaging technologies. Technological innovations continue to enhance the effectiveness of imaging solutions, consequently increasing demand for associated consumables as healthcare providers strive to improve patient care and diagnostic accuracy.

Systems (Dominant) vs. Consumables (Emerging)

The systems segment remains the dominant force in the US breast imaging market, characterized by advanced technologies that improve diagnostic capabilities and patient outcomes. This segment includes state-of-the-art digital mammography systems, which are pivotal in breast cancer screening and detection. In contrast, consumables are regarded as an emerging segment, experiencing robust growth due to the rising demands for specific imaging procedures and enhanced patient management tools. Consumables are essential for optimizing imaging processes, with products such as imaging gels, labeling systems, and disposable materials witnessing increased usage. As systems evolve, the reliance on high-quality consumables is expected to continue growing, underscoring their importance within the overall market dynamics.

### By Application: Screening (Largest) vs. Diagnosis (Fastest-Growing)

In the US breast imaging market, Screening holds the largest share, mainly due to its critical role in early detection and preventive care. It accounts for a significant portion of the total applications in this market, driven by increasing awareness of the importance of regular screenings among women and recommendations from health organizations.

On the other hand, the Diagnosis segment is experiencing the fastest growth, propelled by advancements in imaging technologies and an increasing number of breast cancer cases diagnosed. Factors such as improved diagnostic accuracy and the rising adoption of innovative imaging techniques contribute to the rapid expansion of this area, making it a focal point for future developments in the market.

Screening (Dominant) vs. Diagnosis (Emerging)

Screening remains the dominant application within the US breast imaging market, characterized by its established protocols and widespread acceptance. It plays a vital role in preventive healthcare, leading to early detection of breast cancer, which is crucial for improving treatment outcomes. In contrast, the Diagnosis segment is emerging as a key player, with technologies such as digital mammography and MRI becoming more prevalent. This shift is driven by the need for accurate and efficient diagnosis methods as healthcare providers seek to enhance patient care. The growing reliance on innovative imaging solutions in the Diagnosis segment also indicates a trend towards personalized medicine, offering tailored approaches for patients based on their specific medical needs.

### By End Use: Hospitals (Largest) vs. Diagnostic Centers (Fastest-Growing)

In the US breast imaging market, hospitals dominate the end-use segment, capturing a significant share due to their advanced infrastructure and accessibility to resources. Diagnostic centers, however, are carving out a considerable niche as they provide specialized services and convenience, appealing to a growing consumer preference for outpatient care. The competitive landscape is marked by increasing partnerships between hospitals and diagnostic centers, aiming to enhance service delivery.

Growth trends indicate a robust increase in the demand for breast imaging services across both hospitals and diagnostic centers. Factors such as rising awareness about breast health and advances in imaging technology are driving this market. Moreover, the shift towards preventive healthcare measures and enhanced reimbursement policies further propel the growth of diagnostic centers, making them the fastest-growing option in this segment.

Hospitals (Dominant) vs. Diagnostic Centers (Emerging)

Hospitals in the US breast imaging market are characterized by comprehensive service offerings and advanced imaging technologies, making them the dominant players. They benefit from extensive patient networks and integrated healthcare systems that support seamless referrals and patient care. Conversely, diagnostic centers are emerging as agile and specialized entities that focus on breast imaging, allowing for quicker appointments and tailored services. As healthcare continues to shift towards outpatient models, diagnostic centers are enhancing their capabilities and marketing strategies, making them pivotal in addressing growing patient needs and preferences for convenience and efficiency.

## Competitive Benchmarking

The breast imaging market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing awareness of breast cancer screening, and a growing emphasis on early detection. Major players such as Hologic (US), Siemens Healthineers (DE), and GE Healthcare (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Hologic (US) focuses on innovation in 3D mammography and breast biopsy technologies, while Siemens Healthineers (DE) emphasizes digital transformation and AI integration in imaging solutions. GE Healthcare (US) is leveraging partnerships to expand its product offerings and enhance service delivery, collectively shaping a competitive environment that prioritizes technological sophistication and patient-centric solutions. Key business tactics within the breast imaging market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, fostering competition that drives innovation and improves patient outcomes. In October 2025, Hologic (US) announced the launch of its latest 3D mammography system, which incorporates advanced AI algorithms to improve diagnostic accuracy. This strategic move is significant as it not only reinforces Hologic's commitment to innovation but also positions the company to capture a larger share of the growing demand for precise breast imaging solutions. The integration of AI is likely to enhance the efficiency of radiologists, thereby improving patient care. In September 2025, Siemens Healthineers (DE) unveiled a new digital platform designed to streamline workflow in breast imaging departments. This initiative reflects the company's focus on digital transformation, aiming to reduce operational bottlenecks and enhance the overall efficiency of imaging services. By investing in digital solutions, Siemens Healthineers (DE) is likely to strengthen its competitive edge in a market increasingly driven by technology. In August 2025, GE Healthcare (US) entered into a strategic partnership with a leading telehealth provider to enhance remote diagnostic capabilities for breast imaging. This collaboration is pivotal as it aligns with the growing trend towards telemedicine, allowing for greater accessibility and convenience for patients. By integrating telehealth solutions, GE Healthcare (US) is positioning itself to meet the evolving needs of healthcare providers and patients alike. As of November 2025, current competitive trends in the breast imaging market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition towards a focus on technological innovation, enhanced service delivery, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage.

## Recent News & Developments

In recent months, the US Breast Imaging Market has experienced notable developments, including a focus on advancements in technology and increasing demand for mammography services. Siemens Healthineers announced innovative upgrades to their mammography equipment, enhancing image quality and efficiency. Canon Medical Systems also reported advancements in breast imaging technology, which are expected to improve diagnostic accuracy. In June 2023, Hologic expanded its partnership with Radiology Partners to enhance access to its breast imaging solutions, addressing the increasing need for early detection.

On the mergers and acquisitions front, a significant acquisition occurred in August 2023 when GE Healthcare acquired a minority stake in a breast imaging technology startup, thereby strengthening its portfolio in innovative imaging solutions. The market growth is influenced by the rising prevalence of breast cancer and regulatory initiatives aimed at improving screening programs across the United States. 

Furthermore, the valuation of companies like Philips and Fujifilm has seen positive growth, reflecting strong investor confidence. Over the past few years, from 2021 to 2023, several companies have invested heavily in Research and Development to advance breast imaging technologies, directly impacting patient care and health outcomes.

## Report Scope

| MARKET SIZE 2024 | 1214.39(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 1315.43(USD Million) |
| MARKET SIZE 2035 | 2925.27(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.32% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), Philips (NL), Fujifilm (JP), Canon Medical Systems (JP), Carestream Health (US), Konica Minolta (JP), Agfa HealthCare (BE) |
| Segments Covered | Technology, Product, Application, End Use |
| Key Market Opportunities | Integration of artificial intelligence in breast imaging enhances diagnostic accuracy and operational efficiency. |
| Key Market Dynamics | Technological advancements drive innovation in breast imaging, enhancing diagnostic accuracy and patient outcomes. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the overall market valuation of the US breast imaging market in 2024?**
A: The overall market valuation was 1214.39 $ Million in 2024.

**Q: What is the projected market valuation for the US breast imaging market by 2035?**
A: The projected valuation for 2035 is 2925.27 $ Million.

**Q: What is the expected CAGR for the US breast imaging market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period 2025 - 2035 is 8.32 %.

**Q: Which technology segment had the highest valuation in 2024?**
A: In 2024, the Mammography segment had the highest valuation, ranging from 400.0 to 950.0 $ Million.

**Q: What are the key players in the US breast imaging market?**
A: Key players include Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), and Philips (NL), among others.

**Q: What is the valuation range for the Ultrasound segment in 2024?**
A: The Ultrasound segment had a valuation range of 250.0 to 600.0 $ Million in 2024.

**Q: How does the Breast Biopsy segment's valuation compare to other segments?**
A: The Breast Biopsy segment had a valuation range of 114.39 to 325.27 $ Million, which is lower than other major segments.

**Q: What is the projected valuation for the Software product segment by 2035?**
A: The Software product segment is projected to reach a valuation of 1275.27 $ Million by 2035.

**Q: Which end-use segment is expected to have the highest valuation in 2035?**
A: By 2035, the Hospitals end-use segment is expected to have the highest valuation, ranging from 500.0 to 1200.0 $ Million.

**Q: What is the valuation range for the Diagnosis application segment in 2024?**
A: The Diagnosis application segment had a valuation range of 600.0 to 1300.0 $ Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-breast-imaging-market-53033*